Metagenics Appoints
John Troup, PhD as Chief Science Officer
Metagenics Inc., a nutrigenomics and lifestyle medicine company focused on improving health and reversing chronic illness, recently announced the appointment of John Troup, PhD, as chief science officer and president of its research division, MetaProteomics.
“John Troup is an international leader in the field of nutrition science, health and wellness, developing partnerships with universities and biotech companies, and creating e-health programs supporting the management of chronic illness,” said Fred Howard, chief executive officer of Metagenics. “Under his leadership, our world renowned research organization will enter a new era, expanding their groundbreaking work in the science of nutrigenomics and the discoveries that are helping people around the world to improve their health and reverse chronic illness.”
Troup succeeds Jeffrey Bland, PhD, in this position, as Bland becomes president of the Personalized Lifestyle Medicine Institute (PLMI), a not-for-profit organization supported by Metagenics that is focused on promoting the importance of personalized lifestyle medicine. “With Dr. Troup’s experience working with nutritional companies around the world, I know that he is equipped to help Metagenics in the years to come,” commented Bland.
“I’m convinced that Metagenics is the organization making the scientific breakthroughs that will drive the adoption and success of lifestyle medicine,” said Troup. “Metagenics’ pioneering team of scientists and physicians leads the world in scientifically validating this new approach to combating chronic illness and in developing nutritional therapies that are used by healthcare practitioners around the world. It’s an honor to join them at a time when their work is so vitally important.”
Troup most recently served as vice president of Global Research & Development for Pfizer Nutrition Inc., where he developed a product pipeline with external university and biotech partners, including the development of three global external collaborating centers at major universities. There he also directed cross-functional programsfrom basic research to medical education and e-health initiatives. In previous senior executive positions in nutritional science with Healthspan Solutions, Unilever, Novartis, General Nutrition, and the US Olympic Training Center/United States Swimming, Troup directed research, product development, consumer engagement online programs, health practitioner education, and healthy aging and vitality platforms across all food platforms. In addition to his extensive research and development technical expertise, he is experienced in leading innovation acceleration teams across multiple product formats and categories.
Troup earned his PhD in human metabolism at Marquette University, his master’s of science degree in human bioenergetics at Ball State University, and his bachelor’s of science degree in biology and chemistry at Florida State University.
He will be based at Metagenics’s research campus in Gig Harbor, Washington.
About Metagenics Inc.
Metagenics Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company dedicated to helping people live happier, healthier lives by realizing their genetic potential. Founded in 1983, Metagenics serves more than 75,000 health-care providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs such as FirstLine Therapy to help their patients achieve a lifetime of good health. Metagenics’ scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The company’s educational arm, Metagenics University, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Metagenics maintains its corporate headquarters in Aliso Viejo, California; R&D headquarters in Gig Harbor, Washington; and operating subsidiaries in Brussels, Belgium, and Brisbane, Australia.









0 Comments